Dr. Carl A. Laskin, MD, FRCPC
Managing Director and Founding Partner
Dr. Carl Laskin is an internationally recognized expert in the specialized field of reproductive immunology and autoimmune diseases in pregnancy. He is well known for his clinical and research activities in the field of fertility medicine and recurrent pregnancy loss, as well as pregnancy in women with autoimmune diseases such as systemic lupus. He established the Treatment and Evaluation of Recurrent Miscarriage (TERM) Programme, which quickly became Canada’s largest program devoted to the study and treatment of recurrent pregnancy loss. Today, along with Dr. Sony Sierra, Dr. Laskin runs the RPL program at TRIO, the largest program in Canada focused on the investigation and management of recurrent pregnancy loss.
Dr. Laskin has been invited to present the results of his research on the role of the immune system in recurrent pregnancy loss at numerous international medical conferences in North America and Europe. His research has been published in the New England Journal of Medicine, as well as many other peer-reviewed publications.
Dr. Laskin is the Managing Director and a Founding Partner of TRIO Fertility. He is also an Associate Professor in the departments of Medicine (Obstetric Medicine Program) and Obstetrics and Gynecology at the University of Toronto, as well as a Past President of the Canadian Fertility and Andrology Society (CFAS). He remains actively involved in this organization, and is currently on the Government Relations Committee.